Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical Kidney Journal, 2023 - academic.oup.com
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

[HTML][HTML] Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical Kidney Journal, 2023 - ncbi.nlm.nih.gov
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical Kidney Journal, 2023 - go.gale.com
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical Kidney Journal, 2023 - researchinformation.amsterdamumc …
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical Kidney Journal, 2023 - search.ebscohost.com
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

[PDF][PDF] Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical Kidney Journal, 2023 - academic.oup.com
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical Kidney Journal, 2023 - europepmc.org
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - Clinical kidney journal, 2023 - pubmed.ncbi.nlm.nih.gov
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …

[PDF][PDF] Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

MG Vervloet - 2023 - repository.ubn.ru.nl
The increased cardiovascular risk of chronic kidney disease may in part be the
consequence of arterial stiffness, a typical feature of kidney failure. Deranged homeostasis …